131 related articles for article (PubMed ID: 18949411)
1. Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.
Sasaki H; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Oncol Rep; 2008 Nov; 20(5):1125-30. PubMed ID: 18949411
[TBL] [Abstract][Full Text] [Related]
2. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
Thussbas C; Nahrig J; Streit S; Bange J; Kriner M; Kates R; Ulm K; Kiechle M; Hoefler H; Ullrich A; Harbeck N
J Clin Oncol; 2006 Aug; 24(23):3747-55. PubMed ID: 16822847
[TBL] [Abstract][Full Text] [Related]
3.
Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
[TBL] [Abstract][Full Text] [Related]
4. EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.
Sasaki H; Okuda K; Shimizu S; Takada M; Kawahara M; Kitahara N; Okumura M; Matsumura A; Iuchi K; Kawaguchi T; Kubo A; Kawano O; Yukiue H; Yano M; Fujii Y
J Cancer Res Clin Oncol; 2009 Feb; 135(2):313-8. PubMed ID: 18726117
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.
Quintanal-Villalonga Á; Carranza-Carranza A; Meléndez R; Ferrer I; Molina-Pinelo S; Paz-Ares L
Clin Lung Cancer; 2017 Nov; 18(6):667-674.e1. PubMed ID: 28583379
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
[TBL] [Abstract][Full Text] [Related]
7. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
[TBL] [Abstract][Full Text] [Related]
8. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
[TBL] [Abstract][Full Text] [Related]
9. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
[TBL] [Abstract][Full Text] [Related]
10. FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer.
Fang HM; Tian G; Zhou LJ; Zhou HY; Fang YZ
Acta Pharmacol Sin; 2013 Apr; 34(4):549-54. PubMed ID: 23524567
[TBL] [Abstract][Full Text] [Related]
11. FGFR4 polymorphism, TP53 mutation, and their combinations are prognostic factors for oral squamous cell carcinoma.
Tanuma J; Izumo T; Hirano M; Oyazato Y; Hori F; Umemura E; Shisa H; Hiai H; Kitano M
Oncol Rep; 2010 Mar; 23(3):739-44. PubMed ID: 20127014
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Significance of FGFR4 Gly388 Polymorphism in Esophageal Squamous Cell Carcinoma after Concurrent Chemoradiotherapy.
Shim HJ; Shin MH; Kim HN; Kim JH; Hwang JE; Bae WK; Chung IJ; Cho SH
Cancer Res Treat; 2016 Jan; 48(1):71-9. PubMed ID: 25989802
[TBL] [Abstract][Full Text] [Related]
13. FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
Marmé F; Werft W; Benner A; Burwinkel B; Sinn P; Sohn C; Lichter P; Hahn M; Schneeweiss A
Ann Oncol; 2010 Aug; 21(8):1636-1642. PubMed ID: 20147743
[TBL] [Abstract][Full Text] [Related]
14. The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma.
da Costa Andrade VC; Parise O; Hors CP; de Melo Martins PC; Silva AP; Garicochea B
Exp Mol Pathol; 2007 Feb; 82(1):53-7. PubMed ID: 17084840
[TBL] [Abstract][Full Text] [Related]
15. FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients.
Streit S; Mestel DS; Schmidt M; Ullrich A; Berking C
Br J Cancer; 2006 Jun; 94(12):1879-86. PubMed ID: 16721364
[TBL] [Abstract][Full Text] [Related]
16. A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer.
Sasaki H; Okuda K; Takada M; Kawahara M; Kitahara N; Matsumura A; Iuchi K; Kawaguchi T; Kubo A; Endo K; Kawano O; Yukiue H; Yano M; Fujii Y
J Cancer Res Clin Oncol; 2008 Dec; 134(12):1371-6. PubMed ID: 18478265
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor receptor 4 single nucleotide polymorphism Gly388Arg in head and neck carcinomas.
Wimmer E; Ihrler S; Gires O; Streit S; Issing W; Bergmann C
World J Clin Oncol; 2019 Mar; 10(3):136-148. PubMed ID: 30949443
[TBL] [Abstract][Full Text] [Related]
18. Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis.
Matakidou A; El Galta R; Rudd MF; Webb EL; Bridle H; Eisen T; Houlston RS
Br J Cancer; 2007 Jun; 96(12):1904-7. PubMed ID: 17519899
[TBL] [Abstract][Full Text] [Related]
19. Is FGFR4 Gly388Arg missense variant a suitable prognostic marker in neuroblastoma?
Katarzyna S
J Cancer Res Ther; 2023; 19(2):355-358. PubMed ID: 37006072
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the FGFR4 Arg388 allele in head and neck squamous cell carcinoma.
Streit S; Bange J; Fichtner A; Ihrler S; Issing W; Ullrich A
Int J Cancer; 2004 Aug; 111(2):213-7. PubMed ID: 15197773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
